This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Time to talk about the difference between meaningful data and background noise.

Hoffman shows how the 'reality points' theory can help you time stock purchases.

While it seems that biotech stocks move at random, there could be some method to the madness after all.

Celera Says Done!

04/06/00 - 09:56 AM EDT

The Celera announcement will have a major effect on biotech companies -- not all of which will be good.

Even if genomics companies continue to slide, others will do well, says our new biotech columnist.

Our new columnist views the sector from the perspective of a buy-side professional.

Page 1 of 1
< Previous
Next >
Top Rated Stocks Top Rated Funds Top Rated ETFs